Check out your Company Bowl for anonymous work chats.
In recognition of World Environment Month, Genmab colleagues in Japan were proud to continue our longstanding partnership with Maggie’s Tokyo by helping beautify their garden for visitors to enjoy. Maggie’s Tokyo is a welcoming place where people living with cancer, as well as their families and friends, can connect with healthcare professionals and receive support. Through this volunteer activity, we aimed to help maintain a peaceful space for patients and their loved ones. This meaningful project reflects Genmab’s commitment to supporting environmental initiatives and patient communities and creating a positive impact in the communities where we live and work.
Welcome to Genmab’s June Edition of Knock-Your-Socks-Off-News, a monthly newsletter covering our current happenings across the globe. Follow along with us on our journey for more updates as we advance innovation and continue to work towards our goal of transforming the lives of patients through antibody medicines.
We’re pleased to announce that Margarida Duarte has joined Genmab as General Manager for Europe and Emerging Markets. This appointment marks an important step as we continue to strengthen our presence across the region and work to bring innovative antibody medicines to more patients. Welcome, Margarida, to Genmab! Read more here: http://gmab.ly/AXfe50YzjrE.
Learn how Genmab began with a bold idea to harness the power of antibodies to fight cancer and other serious diseases and how that vision is now making an impact for patients. From challenging the status quo to leveraging data-driven insights, this video highlights how we are advancing antibody medicines with patients at the center of every step.  At Genmab, we don’t just focus on antibodies — we focus on the people behind every breakthrough. 
Three Genmab colleagues were recently elected to our Board of Directors for a three-year term, continuing our long-standing tradition of employee representation. This ensures our team’s voice is part of decision-making and strengthens our culture of collaboration and innovation. Congratulations Martin Schultz, Mijke Zachariasse and Mike Kavanagh on being elected to our board of directors by Genmab colleagues!
ICYMI: We recently published our 2024 Annual Report. Executive Vice President and Chief Financial Officer Anthony Pagano shares how our strategic investments and focus on late-stage programs are driving our evolution into a biotech innovation powerhouse. Read the report: http://gmab.ly/uvbl50UYQ4c
We had the privilege of hosting the heartwarming BioNJ “Give Back” initiative. Our colleagues and BioNJ members built “Bio Bears” dressed in super-hero capes, to be donated to patients at Children’s Specialized Hospital in New Jersey. This event reflects Genmab’s commitment to giving back to the community and bringing hope to patients in need. Learn more about our community at Genmab here: http://gmab.ly/yZic50UavXv.
We’ve been selected for the fourth consecutive year as one of NJBIZ’s Best Places to Work in New Jersey for 2024! 🎉 When you are part of Genmab, you will be part of the extra[not]ordinary®. Our unique word represents how we go way beyond what is usual: to be remarkable, proudly unique and authentic. Learn how you can join our team today! http://gmab.ly/xJoe50TxhvI.
#InvestorUpdate: We’ve published our Interim Report for the first nine months of 2024. Hear from Anthony Pagano, Executive Vice President & Chief Financial Officer on our progress toward our goal to impact patients’ lives with antibody medicines.
In recognition of Veterans Day, we are spotlighting our colleague Trish Lopaz, who spends time volunteering with Semper Fido, Inc., an organization dedicated to supporting wounded veterans with PTSD and Traumatic Brain Injury by pairing them with rescue dogs trained as service animals. Thank you, Trish, for all you do for the veteran community. We are also proud to support Community Hope, a New Jersey-based organization providing essential social services to Veterans.
